Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA delays approval of UCB epilepsy drug
The company submitted a new drug application to the FDA seeking approval for the intravenous administration of the drug in adjunctive therapy for the treatment of partial onset
The company submitted a new drug application to the FDA seeking approval for the intravenous administration of the drug in adjunctive therapy for the treatment of partial onset
The drug is the only treatment currently available in the US for the prevention of the disease. There has been a gap in the market for such a
The product tests for H5 influenza of which bird flu (H5N1) is a subtype. The test returns results on a sample within four hours, compared with the two
The study in 48 young healthy subjects, of whom 36 received EVT 101, showed that the drug was well absorbed, extremely well tolerated with no significant adverse events,
The company will evaluate Combretastatin A4P (CA4P), in combination with concurrent chemo-radiotherapy, a widely accepted standard in the US for the treatment of unresectable stage IIIa/IIIb non small
The trial, known as MIRA-1, did not demonstrate a statistically significant difference in the mean change of best spectacle-corrected visual acuity between the treated and placebo groups at
If approved, SPD476 would offer a once-daily mesalazine treatment for the disorder. Last year, the mesalazine market segment for ulcerative colitis was worth around $1.6 billion. “The European
Neuroblastoma is the most common extracranial solid tumor in children younger than five years of age. Despite advances in modern therapy, metastatic neuroblastoma remains incurable. One barrier to
The open-label study enrolled eight patients with normal testosterone levels, four with borderline testosterone levels, and one with low testosterone. Study subjects received 25mg of Androxal orally for
The findings resulted from laboratory experiments conducted at Cedars-Sinai Medical Center’s Maxine Dunitz Neurosurgical Institute and are based on the manipulation of a series of intricate biochemical events